Clinical Trial Update: Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for allogenic adipose-derived mesenchymal stem cells to treat knee osteoarthritis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Allogenic Adipose-Derived Mesenchymal Stem Cells

Snippet

Sponsor: Wuxi Cellular Biopharmaceutical Group Ltd. | Conditions: Knee Osteoarthritis | Phase 3 | Status: RECRUITING